Ceritinib Nitroso Impurity 2
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Ceritinib is used to treat metastatic (cancer that has already spread) non-small cell lung cancer in patients who have a certain type of abnormal anaplastic lymphoma kinase (ALK) gene. Your doctor will test for the presence of this gene. Ceritinib is an antineoplastic (cancer) agent.Ceritinib Nitroso Impurity 2 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
Ceritinib Nitroso Impurity 2 CAS NO:NA chemically represented as N-(5-Chloro-4-((2-(isopropylsulfonyl)phenyl)amino)pyrimidin-2-yl)-N-(2-isopropoxy-5-methyl-4-(piperidin-4-yl)phenyl)nitrous amide. Synchemia is the leading manufacturing and exporter of Ceritinib Nitroso Impurity 2 . We supply Ceritinib Nitroso Impurity 2 with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N014355 |
| CAS No | 2742659-60-3 |
| Mol.F. | C8H13N3O2 |
| Mol.Wt. | 183.2 |
| INV STATUS | In Stock |
| CAT No | SRC-N014356 |
| CAS No | NA |
| Mol.F. | C19H18FN3O2 |
| Mol.Wt. | 339.4 |
| INV STATUS | In Stock |
| CAT No | SRC-N014357 |
| CAS No | NA |
| Mol.F. | C11H15N3O2S |
| Mol.Wt. | 253.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014358 |
| CAS No | NA |
| Mol.F. | C13H15ClN2O2 |
| Mol.Wt. | 266.7 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014359 |
| CAS No | 678982-38-2 |
| Mol.F. | C23H24I2N2O4 |
| Mol.Wt. | 646.26 g/mol |
| INV STATUS | In Stock |
| CAT No | SRC-N014360 |
| CAS No | NA |
| Mol.F. | C30H25F4N7O2 |
| Mol.Wt. | 591.6 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014361 |
| CAS No | 2219339-13-4 |
| Mol.F. | C10H12ClN3O |
| Mol.Wt. | 225.7 g/mol |
| INV STATUS | In Stock |
| CAT No | SRC-N014362 |
| CAS No | 1850-88-0 |
| Mol.F. | C10H14N2O2 |
| Mol.Wt. | 194.2 |
| INV STATUS | In Stock |
| CAT No | SRC-N014363 |
| CAS No | NA |
| Mol.F. | C14H19N5O3 |
| Mol.Wt. | 305.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014365 |
| CAS No | NA |
| Mol.F. | C34H33F5N4O6 |
| Mol.Wt. | 688.7 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014366 |
| CAS No | 55557-03-4 |
| Mol.F. | C14H18N2O3 |
| Mol.Wt. | 262.3 g/mol |
| INV STATUS | In Stock |
| CAT No | SRC-N014367 |
| CAS No | NA |
| Mol.F. | C7H13N3O |
| Mol.Wt. | 155.2 |
| INV STATUS | In Stock |
| CAT No | SRC-N014368 |
| CAS No | NA |
| Mol.F. | C8H4F3N3O |
| Mol.Wt. | 215.1 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014364 |
| CAS No | 932-83-2 |
| Mol.F. | C6H12N2O |
| Mol.Wt. | 128.2 |
| INV STATUS | In Stock |
| CAT No | SRC-N014369 |
| CAS No | 86144-35-6 |
| Mol.F. | C13H15ClN2O2 |
| Mol.Wt. | 266.7 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014370 |
| CAS No | NA |
| Mol.F. | C13H15ClN2O2 |
| Mol.Wt. | 266.7 |
| INV STATUS | CUSTOM SYNTHESIS |